mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.003 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |